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522a Tuesday, February 18, 2014the coexpressedGPCRsEP2 or EP4 results in clearly distinguishable effects even
though both receptors activate the Gs-cAMP signaling pathway. Themechanism
regulating these distinct signaling outcomes remains unclear. Here we show that
EP4, in contrast to EP2, dynamically localize in elongated areas of the plasma
membrane that are dictated by the underlying cortical microtubule network.
For EP4, this results in efficient but transient cAMP production throughout a
range of PGE2 concentrations. In contrast, EP2 induces marginal but continuous
cAMP levels.We propose amodel where, differently from actin corrals and tran-
sient confienemtn zones, cortical microtubules form scaffolds for signaling hubs
visited by receptor diffusing within the plasmamembrane. This leads to efficient
regulation of this GPCR signaling function, which is important to regulate cyto-
skeleton remodeling and migration in leukocytes and cancer cells.
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Sensing of extracellular matrix (ECM) physical properties is critical for several
processes such as cell differentiation, cell migration in the developmental (hap-
totaxis) and disease (cancermetastasis). Clustering ofmatrix-activated integrins
is an important step in the formation ofmatrix adhesions and clustering can occur
by lateral association of activated integrin receptors. Using supported bilayers
with fluid, lipid-linked RGD ligands, large clusters of activated integrins formed
in bound mouse embryo fibroblasts (Yu et al., 2011. PNAS 108:20585). After
cells spread on RGD bilayers for 15 minutes, integrin clusters were formed
even in the presence of inhibitors of cytoskeletal assembly. We have quantified
the cluster size, geometry and receptor distribution at a nanometer level using
photoactivated light microscopy. When the temperature was decreased to
250C, the cluster formation was greatly diminished, indicating that the integrin
cluster formation may be an entropically driven process. To identify the players
crucial for this process, we observed that when Talin1 knockout cells spread, the
cluster size and the position of the clusters around the cell was altered. This was
rescued by a full length Talin construct, indicating that Talin is required for the
early cluster formation. This was also rescued by Talin head domain and not by
Talin rod domain, indicating that most likely in the absence of external force, the
integrin activation by Talin head was required for cluster to form. This study
shows that the integrin cluster formation proceeds in the absence of external trac-
tion force in aTalin1 dependentmanner. Thus,we suggest that talin head binding
is an important factor in integrin clustering.
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We present a simple model of a membrane bound protein allosterically regu-
lated by the local lipid composition. We are motivated by the experimental
finding that the plasma membranes of mammalian cells are tuned close to a
liquid-liquid critical point, where the sensitivity of many properties to pertur-
bations is large. We consider a protein whose boundary conditions with the sur-
rounding membrane are dependent on its functional state (i.e. conducting vs.
non-conducting for an ion channel). For such a protein we show that small
changes in the chemical potential of lipids can lead to dramatic functional
changes near a critical point. This type of regulation becomes more potent as
the protein becomes larger, and as the membrane gets closer to a critical point.
Such a protein would also have its nanometer-scale localization correlated with
its functional state. A cell could regulate such a protein by adjusting the compo-
sition either by changing the ratio of ordered to disordered lipids (experimen-
tally probed by cholesterol depletion and loading) or by raising or lowering the
critical temperature. Here we focus on perturbations that act to lower the crit-
ical temperature, like the liquid general anesthetics that have been shown to
lower critical temperatures by ~4K at clinically relevant concentrations. We
show that this change is sufficient to lead to changes in channel conductivity
in line with what has been shown for a wide class of channels even without
specific interactions between perturbing molecules and the channel itself.
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Chemotaxis, the directed migration of cells in chemical gradients, is a vital
function in many biological processes, for example, morphogenesis and syn-apse formation. In chemotaxis of many eukaryotic cells, the localization of
some key signaling mediators on the cell membrane regulates cell movements.
Chemotaxis of Dictyostelium cells is mediated by some parallel signaling path-
ways like phosphoinositide-3-kinase (PI3K) pathway, soluble guanylate cycla-
se(sGC) pathway and so on. Previous work demonstrated that the response to
chemoattractant, cyclic adenosine monophosphate (cAMP), of PI3K pathway
has some characteristics of an excitable system. The theoretical model shows
that this excitable pathway can regulate cell unidirectional movements in
respond to a chemical gradient efficiently. However, what kind of property
sGC pathway has remains to be clarified and it also remains unknown about
the interaction between the sGC pathway and the PI3K pathway.
Here, we studied that the sGC pathway also is an excitable system by analyzing
the spatiotemporal dynamics of sGC. We found that focal sGC-enriched
domains were spontaneously generated in a no external stimulus condition.
The sGC-enriched domain generated spontaneously had same property with
the domains induced by cAMP stimulation. These features are characteristics
of an excitable system like the PI3K pathway. We will report that the dynamics
of the PI3K pathway is influenced by modulation of the sGC pathway.
The chemotactic signal transduction consists of multiple excitable pathways.
This structure of signaling system may increase efficiency of respond to the
steep gradient of cAMP.
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The voltage sensitive phosphatase Ci-VSP is generally considered to be a
PI(4,5)P2/PI(3,4,5)P3-5-phosphatase in-vivo, while 3-phosphatase activity
could be demonstrated in-vitro using the isolated catalytic domain of
Ci-VSP. However, a recent study demonstrates PI(3,4)P2-3-phosphatase activ-
ity of Ci-VSP expressed in Xenopus laevis oocytes (Kurokawa et al, 2012,
PNAS). This is in contrast to our previous findings obtained in Chinese hamster
ovary (CHO) cells (Halaszovich et al., 2009, JBC).
We set out to do a careful re-evaluation of Ci-VSP’s specificity in oocytes as
well as CHO cells. TAPP1-PH-GFP was used as the PI(3,4)P2 sensor. In
some experiments, the resting level of PI-3-phosphates was increased using
either co-expression of a constitutively active PI-3-kinase or stimulation of
endogenous IGF-receptors with insulin. Membrane binding of TAPP1-PH-
GFP as a measure of [PI(3,4)P2] was quantified using fluorescence microscopy
(confocal LSM for oocytes, TIRF microscopy for CHO cells). The membrane
voltage of oocytes was controlled using the two-electrode voltage-clamp tech-
nique, for CHO cells the patch-clamp technique was used.
We failed to demonstrate 3-phosphatase activity against PI(3,4)P2 in oocytes
but always detected production of this phosphoinositide species, which presum-
ably reflects PI(3,4,5)P3-5-phosphatase activity of heterologously expressed
Ci-VSP as well as endogenous VSPs. However, in Ci-VSP expressing CHO
cells we could detect a reduced increase, but not a decrease in TAPP1-
PH-GFP binding to the cell membrane at high voltages. This reduction
probably reflects PI(3,4)P2-3-phosphatase activity and not reduced PI(3,4,5)
P3-5-phosphatase activity.
In conclusion, our findings show an overall production of PI(3,4)P2 over the
whole voltage range studied. Therefore we presume that under physiological
conditions the PI(3,4,5)P3-5-phosphatase activity of Ci-VSP outweighs its
PI(3,4)P2-3-phosphatase activity.
Supported by University Medical Center Giessen and Marburg (UKGM 32/
2011 MR) to C.R.H. and Deutsche Forschungsgemeinschaft (SFB593 TP
A12) to D.O.
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3’-phosphoinositide dependent kinase-1 (PDK1) plays a central role in the
transduction of signals downstream phosphoinositide 3-kinase (PI3K), a
pathway often found deregulated in tumours. PDK1 regulation is known to
respond to phosphatidylinositol(3, 4, 5)trisphosphate (PtdIns(3,4,5)P3) levels
and it has been recently shown that its PH domain specifically binds to
Tuesday, February 18, 2014 523aphosphatidylserine (PtdSer) at the PM [1]. Previous studies have shown that
PDK1 homodimerisation is essential for its regulating activity [2].
Our goal is to elucidate the role of PtdIns(3,4,5)P3 and PtdSer in the homodi-
merisation mechanism of PDK1. Measuring Fo¨rster Resonance Energy Trans-
fer (FRET) by Fluorescence Lifetime Imaging Microscopy (FLIM) we have
studied the spatial and temporal distribution of the homodimeric population
of wild-type and point mutants of PDK1 with decreased affinity for
PtdIns(3,4,5)P3 and PtdSer on individual human breast cancer cells (SK-
BR-3) and non-cancerous mouse fibroblasts (NIH-3T3) before and after growth
factor stimulation. Based on the statistical comparison of these populations, we
have established the critical and cooperative role of both phospholipids for the
recruitment of this kinase at the PM and its subsequent regulation through the
intermolecular organisation of homodimers.
1. Lucas N and Cho W (2011) Phosphatidylserine Binding Is Essential for
Plasma Membrane Recruitment and Signaling Function of 3-Phosphoinositide-
dependent Kinase-1. J Biol Chem 286: 41265-41272.
2. Masters TA, Calleja V, Armoogum DA et al (2010) Regulation of
3-Phosphoinositide-Dependent Protein Kinase 1 Activity by Homodimeriza-
tion in Live Cells. Science Signaling 3(145): ra78.
2647-Pos Board B339
HER2 Overexpression Induces Membrane Deformation that Increases
Cell Motility
Inhee Chung, Mike Reichelt, Don Dowbenko, Ira Mellman,
Mark Sliwkowski.
Genentech, South San Francisco, CA, USA.
Approximately 20% of breast cancers (BC) are characterized by the gene
amplification and overexpression of HER2, a member of the ErbB/HER recep-
tor family. While targeted therapies against HER2 effectively delay disease
progression in this BC subtype, details of how overexpressed HER2s drive
these tumors to malignancy are still unclear. To better understand this process,
we investigated cellular responses to HER2 overexpression in individual live
cells. We developed novel single receptor diffusion analyses to probe the
spatial distribution of HER2s and determine their activation status by their
diffusivity. Surprisingly, we found that HER2 overexpression induced defor-
mation of basal cell membranes, which depended only on the HER2 density,
regardless of the receptor signaling activity. Moreover, this membrane defor-
mation lowered the focal adhesion coverage on the cell surface, which reduced
cell adhesion and increased cell motility. These findings suggest that there is a
signaling-independent role of HER2 overexpression in disease progression of
HER2 positive BCs.
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Glioblastoma multiforme (GBM) is the most clinically aggressive primary
brain tumor and is characterized by diffuse infiltration of glioma cells into brain
parenchyma, which is rich in the glycosaminoglycan hyaluronic acid (HA). The
extracellular matrix of GBM tumors is associated with aberrant HA secretion,
overexpression of the HA receptor CD44, and tissue stiffening. Here we
combine matrix engineering and genetic manipulation of GBM tumor cells
to determine the role of HA/CD44 adhesion in the outputs of cell adhesion,
migration, and invasion. We show that HA/CD44 adhesion contributes to the
mechanosensing and invasive motility of GBM tumor cells, both intrinsically
and in the context of RGD/integrin adhesion. We also find that three-
dimensional cell invasion is maximized in an HA-rich environment, but
reduction of CD44-based adhesion or addition of integrin-adhesive peptides
to the matrix suppresses invasion. While comparatively much is known about
cell-matrix mechanosensing through integrins and the role it may play in tumor
progression, our findings reveal a previously under-appreciated role of CD44
and possibly other HA-specific receptors in this process. These findings have
broad implications for the field’s fundamental understanding of how cancer
cells interact with the tumor microenvironment and suggest new therapeutic
strategies.
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HER3 (or ErbB3) is a member of the human epidermal growth factor receptor
(HER/EGFR) family of receptor tyrosine kinases. HER3 carries inactivating
mutations in its kinase domain and therefore is denoted as a pseudokinase.
Despite lacking catalytic activity, the pseudokinase domain of HER3 playsan important role in activating EGFR and HER2 kinases, resulting in potent
downstream signaling. Recent advancements in cancer research identify
HER3 as an important therapeutic target in breast, lung, gastric, ovarian and
colorectal cancers, but due to HER3’s pseudokinase status, its inhibition re-
mains a major challenge. Our past work demonstrated that the pseudokinase
domain of HER3 tightly binds ATP. This finding suggested an exciting oppor-
tunity - it might be possible to regulate HER3 signaling through modulation of
its nucleotide-binding pocket. However, due to lack of available compounds,
this idea was left untested. Here we are reporting that the allosteric activator
function of HER3 can be modulated through this site via the ATP-
competitive inhibitor bosutinib. We present a first structure of the HER3 pseu-
dokinase domain with an inhibitor, bosutinib, bound in the nucleotide-binding
site. To our knowledge, this is the first structure of any pseudokinase bound to
an inhibitor. We then perform in vitro assays to show for the first time that
HER3 function can be modulated through small molecule binding to the
nucleotide-binding pocket. Although we show that bosutinib has the opposite
effect from what is desired in cancer therapies, our study provides the proof
of principle for small molecule regulation of the HER3 function. This finding
opens an exciting direction for the generation of a new class of HER3-specific
therapeutics that directly target the pseudokinase domain.
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Trastuzumab is the most commonly used humanized monoclonal antibody for
specific therapy of breast cancer. Even though its clinical introduction was a
breakthrough, a large fraction of the treated tumors are or become resistant.
It is well known that receptor internalization and recycling are crucial
for ErbB2 mediated signal transduction. Accordingly, inhibition of its mole-
cular machinery could provide alternatives for tumor treatment. Vacuolar
Hþ-ATPase (V-ATPase) is involved in the regulation of endocytotic/recycling
pathways. Archazolid-B was described as a potent V-ATPase inhibitor, which
induces apoptosis and impairs migration of tumor cells. Based on these obser-
vations we investigated the effect of Archazolid on trastuzumab-resistant Jimt-
1 cells in vitro and in vivo. 10nM of Archazolid caused decreased membrane
ErbB2 expression, which was accompanied by the reduced relative phosphor-
ylation on Y1248 and intracellular accumulation of the receptors. As an in vivo
model, SCID mice were transplanted with Jimt-1 xenografts and treated with
Archazolid. Following administration of the V-ATPase inhibitor there was a
significant decrease in tumor growth compared to control tumors. Confocal
microscopic images of tumor sections showed heterogeneous distribution of
the proliferation marker Ki67 positivity. Tumor areas with low Ki67 nuclear
expression showed intracellular accumulation of ErbB2 molecules similarly
to the in vitro experiments, compared to high Ki67 expressing areas with prom-
inent membrane ErbB2 expression. This heterogeneity might be due to diverse
tumor-vascularization. Our results demonstrate that Archazolid can be used for
in vitro and in vivo tumor growth inhibition based on its interference with
ErbB2 recycling.
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Parkinson’s disease (PD) is a neurodegenerative disorder due to reduced dopa-
mine (DA) in the striatum and loss of DA neurons in the substantia nigra pars
compacta. Embryonic stem cells (ESCs) are an optimal source for cell therapy
for PD.We recently developed a fast (one-week) protocol using small molecules
that effectively induces human ESCs to become primitive neural stem cells
(pNSCs), which are then differentiated into DA-like neurons in vitro. As pNSCs
are infinitely expandable, this approach offers a strategy to readily generate DA
neurons on a large scale. But whether these pNSC-differentiated DA (pNSC-
DA) neurons can functionally integrate into the damaged brain is unknown.
